Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin (B03Xa01) Within The Framework Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 93398071

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient erythropoietin (B03XA01) within the period from November 1, 2024 t o October 31, 2026 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list according to Section 35 Paragraph 5a SGB V (medicines for children) are excluded.notice_title: Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoi

Gt Ref Id - 93398071

Deadline - Aug 31, 2026